Overview

Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The aim of the current study is to compare the analgesic effects of both drugs in patients with obesity undergoing bariatric surgery.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Ibuprofen
Ketorolac